Analysing a clinical paper on an intervention study
Synthesising primary studies (meta analysis and systematic reviews)
Clinical significance - what does it mean to the patient?
Students can enrol in this program anytime up to the enrolments close date as specified below, as long as they are confident they can complete the mandatory assessment by semester close.
If you have a result for this program, you can view it here (login required).
Dates
2010 Semester 1
Enrolments open
10 November 2009
Study period commences
11 January 2010
Enrolments close
24 May 2010
Last possible exam date
and semester close
27 June 2010
STOP! If you work for an enterprise that regularly sponsors students to participate in Medicines Australia CEP, then you should not enrol through this process.
Contact the CEP Company Coordinator at your enterprise to arrange program enrolment. If you are unsure, contact us.
The enrolment fee for this program is AU$757.90 including GST.
Payment for program enrolment is by internet payment or BPAY, so have your electronic payment details ready prior to commencing the enrolment process.
Enrolments will be confirmed once payment has been processed. Notification of enrolment will occur by mail.
Already
enrolled?
Are you already
enrolled? Login
for access.
Audience
Pharmaceutical company representatives.
Timetable
This program runs from 11 January to 27 June 2010.
Presented by The University of Queensland, UQ Health Insitu and Medicines Australia